Risk of relapse in patients with non-seminomas was not associated with tumor size or LHCGR (Figure 4I,J), but patients experiencing relapse had higher serum level of hCG (p = 0.0097) and AFP (p = 0.025) at the time of diagnosis (Figure 4K,L). This evidence concerns the gene AFP and neoplasm.